sb 203580 has been researched along with oleuropein in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (oleuropein) | Trials (oleuropein) | Recent Studies (post-2010) (oleuropein) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 583 | 15 | 433 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giner, E; Giner, RM; Recio, MC; RĂos, JL | 1 |
1 other study(ies) available for sb 203580 and oleuropein
Article | Year |
---|---|
Oleuropein protects against dextran sodium sulfate-induced chronic colitis in mice.
Topics: Animals; Anti-Inflammatory Agents; Colitis; Cyclooxygenase 2; Dextran Sulfate; Interleukin-10; Interleukin-1beta; Interleukin-6; Intestinal Mucosa; Iridoid Glucosides; Iridoids; Mice; Mice, Inbred C57BL; Molecular Structure; Nitric Oxide Synthase Type II; Olea; p38 Mitogen-Activated Protein Kinases; Pyrans; T-Lymphocytes | 2013 |